SEC Form 4 · accession 0002130205-26-000002
ALTERITY THERAPEUTICS LTD · ATHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Allen Stamler
Officer — Chief Executive Officer · Director
Period of report
Aug 31, 2026
Accepted (ET)
Sep 8, 2026 · 6:52 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001131343
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Listed option exp 31 Aug 2026 | $0.50 | Aug 31, 2026 | P | 47,620 | D | Apr 15, 2026 | Aug 31, 2026 | Ordinary shares | 47,620 | 0 | D |